Safety of subcutaneous immunotherapy with inhalant allergen extracts: a single-center 30-year experience from Turkey

---

Kartal O., Gulec M., Caliskaner Z., Musabak U., Sener O.

IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, cilt.37, sa.3, ss.280-286, 2015 (SCI-Expanded)

• Yayın Türü: Makale / Tam Makale
• Cilt numarası: 37 Sayı: 3
• Basım Tarihi: 2015
• Doi Numarası: 10.3109/08923973.2015.1027918
• Dergi Adı: IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
• Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Sayfa Sayıları: ss.280-286
• Hacettepe Üniversitesi Adresli: Hayır

Özet

Context: Although subcutaneous allergen immunotherapy (SCIT) is effective in allergic rhinitis (AR) and asthma, it carries a risk of local and systemic adverse reactions.